Transforming anti fungal therapy sales with PIRL®

Despite proven efficacy of their antifungal therapy, sales of our client’s product had stagnated in a competitive market. Their omnichannel strategy had produced fragmented physician engagement, necessitating a novel approach to uncover actionable insights and drive sales. We were tasked with boosting sales by 15% within a year.

We utilised our AI software, PIRL® to build a data set designed to understand causality in prescribing behaviours. PIRL® provided a 360° view by integrating data on HCP characteristics, disease specifics, the drug landscape (including marketing strategies), cultural factors, peer influence, and hospital context. This holistic dataset produced a vivid and actionable picture of prescribing drivers. PIRL®’s analysis revealed key influencers and barriers, providing the foundation for precision targeting and strategy refinement.

Advanced data aggregation and AI technologies ensured precise segmentation, while tailored messaging leveraged patient narratives to emotionally connect with HCPs. The sales team was strategically activated to prioritise high-impact centres. The results were transformative: prescriptions surged by up to 73% in targeted regions, far exceeding the original objective. This innovative approach not only reinvigorated market penetration but also redefined the strategy for engaging HCPs in the antifungal market.